The global microbial testing market size is estimated to be USD 3,917.5 Million in 2021 and is expected to witness a CAGR of 6.96% during the forecast period. Growing private-public funding for research and development on infectious diseases is a key driver for the growth of the global microbial testing market. Additionally, technological advancements in the microbiology testing market along with rising burden of infectious diseases and outbreak of epidemics are some of the other drivers propelling the market growth. Nevertheless, high cost of microbiology instruments in emerging economies and stringency of regulatory procedures regarding microbial testing are expected to restrain the global market growth.
Based on product, the market is segmented into instruments, which is further segmented into laboratory instruments, microbiology analysers, and reagents. In 2021, the laboratory instruments segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the growing adoption of conservative laboratory instruments by researchers and the academy, technological advancements in the field of molecular techniques and proteomics worldwide. Microbiology analysers segment is projected to grow at a profitable CAGR during the forecast period. This is owing to the rising adoption of laboratory automation in clinical laboratories.
Based on disease area, the market is segmented into bloodstream infections, respiratory diseases, periodontal diseases, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and other diseases. In 2021, the bloodstream infections segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the growing healthcare expenditure globally and increased research funding in the field of infectious diseases. Respiratory diseases segment is projected to grow at a profitable CAGR during the forecast period due to the increasing air pollution that results in various diseases such as lung cancer, heart disease, and respiratory diseases such as emphysema.
Based on application, the market is segmented into pharmaceutical, clinical, food testing, energy, chemical and material manufacturing, and environment. In 2021, the pharmaceutical segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the presence of well-established and globally accepted regulations that govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing worldwide. Clinical segment is projected to grow at a profitable CAGR during the forecast period. This is due to the increasing emphasis on effective and efficient early diagnosis of diseases through the major markets.
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the high penetration of microbial testing among end users, developed technologies for microbial testing, substantial expenditure on healthcare facilities by the people in the region, and presence of well-established distribution channels for microbial testing product manufacturers and suppliers. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to the presence of less stringent regulatory framework, ease in raw material availability, and improved medical facilities in this region. Competitor Insights Some of the major companies in the microbial testing market are 3M Company (U.S.), Accepta Ltd (U.K.), Agilent Technologies Inc. (U.S.), Aquagenx Llc (U.S.), Avantor Performance Materials Llc (U.S.), Biomrieux SA (France), Bio-Rad Laboratories Inc. (U.S.), Dhler Gmbhare (Germany), Biotrack Bv (Netherlands), Danaher Corporation (U.S.). Investment in R&D, novel product launches, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The microbial testing market report is categorized into the following segments and subsegments:
By Product
Based on product, the market is segmented into instruments, which is further segmented into laboratory instruments, microbiology analysers, and reagents. In 2021, the laboratory instruments segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the growing adoption of conservative laboratory instruments by researchers and the academy, technological advancements in the field of molecular techniques and proteomics worldwide. Microbiology analysers segment is projected to grow at a profitable CAGR during the forecast period. This is owing to the rising adoption of laboratory automation in clinical laboratories.
By Disease Area
Based on disease area, the market is segmented into bloodstream infections, respiratory diseases, periodontal diseases, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and other diseases. In 2021, the bloodstream infections segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the growing healthcare expenditure globally and increased research funding in the field of infectious diseases. Respiratory diseases segment is projected to grow at a profitable CAGR during the forecast period due to the increasing air pollution that results in various diseases such as lung cancer, heart disease, and respiratory diseases such as emphysema.
By Application
Based on application, the market is segmented into pharmaceutical, clinical, food testing, energy, chemical and material manufacturing, and environment. In 2021, the pharmaceutical segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the presence of well-established and globally accepted regulations that govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing worldwide. Clinical segment is projected to grow at a profitable CAGR during the forecast period. This is due to the increasing emphasis on effective and efficient early diagnosis of diseases through the major markets.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the high penetration of microbial testing among end users, developed technologies for microbial testing, substantial expenditure on healthcare facilities by the people in the region, and presence of well-established distribution channels for microbial testing product manufacturers and suppliers. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to the presence of less stringent regulatory framework, ease in raw material availability, and improved medical facilities in this region. Competitor Insights Some of the major companies in the microbial testing market are 3M Company (U.S.), Accepta Ltd (U.K.), Agilent Technologies Inc. (U.S.), Aquagenx Llc (U.S.), Avantor Performance Materials Llc (U.S.), Biomrieux SA (France), Bio-Rad Laboratories Inc. (U.S.), Dhler Gmbhare (Germany), Biotrack Bv (Netherlands), Danaher Corporation (U.S.). Investment in R&D, novel product launches, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The microbial testing market report is categorized into the following segments and subsegments:
Microbial Testing Market, By Product (Revenue, 2021-2029, USD Million)
Instruments
- Microbiology Analysers
- Laboratory Instruments
- Reagents
Microbial Testing Market, By Disease Area (Revenue, 2021-2029, USD Million)
- Bloodstream infections
- Respiratory diseases
- Periodontal diseases
- Gastrointestinal diseases
- Sexually transmitted diseases
- Urinary tract infections
- Other diseases
Microbial Testing Market, By Application (Revenue, 2021-2029, USD Million)
- Clinical
- Pharmaceutical
- Food Testing
- Energy
- Chemical and Material Manufacturing
- Environment
Microbial Testing Market, By Region (Revenue, 2021-2029, USD Million)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Table of Contents
1. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Microbial Testing Market
7. Market Analysis by Product
8. Market Analysis by Disease Area
9. Market Analysis by Application
10. Regional Market Analysis
11. North America Microbial Testing Market
12. Europe Microbial Testing Market
13. Asia Pacific Microbial Testing Market
14. Latin America Microbial Testing Market
15. MEA Microbial Testing Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3M Company (U.S.)
- Accepta Ltd (U.K.)
- Agilent Technologies Inc. (U.S.)
- Aquagenx Llc (U.S.)
- Avantor Performance Materials Llc (U.S.)
- Biomrieux SA (France)
- Bio-Rad Laboratories Inc. (U.S.)
- Dhler Gmbhare (Germany)
- Biotrack Bv (Netherlands)
- Danaher Corporation (U.S.)
